Wick M, Zubov D, Hagen G
Bayer AG, Central Research Division, Department of Molecular Biology, D-51368, Leverkusen, Germany.
Gene. 1999 May 17;232(1):97-106. doi: 10.1016/s0378-1119(99)00108-0.
The enzyme telomerase plays a crucial role in cellular proliferation and tumorigenesis. By adding hexameric repeats to chromosome ends, it prevents telomeric loss and, thus, entry into senescence. Recent data suggest that expression of the human telomerase reverse transcriptase subunit (hTERT) represents the limiting factor for telomerase activity. To gain an insight into the mechanisms regulating hTERT expression, we have determined the complete genomic organization of the hTERT gene and isolated the 5'- and 3'- flanking region. The hTERT gene encompasses more than 37kb and consists of 16 exons. We show that all hTERT insertion and deletion variants described so far most likely result from the usage of alternative splice consensus sequences in intron or exon regions. Furthermore, we identified a new hTERT splice variant. Analysis of the DNA sequence surrounding the putative transcriptional start region revealed a TATA-less promoter located in a CpG island. A promoter fragment spanning the first 1100bp upstream of the initiating ATG start codon exhibited high-level activity in HEK-293 cells. Several consensus binding sites for the transcription factor Sp1 as well as a c-Myc binding site were identified in this promoter region. Altogether, these results provide the basis for more detailed studies on the regulation of telomerase activity in normal and cancer cells, and may lead to the development of new cancer therapies.
端粒酶在细胞增殖和肿瘤发生过程中起着至关重要的作用。通过在染色体末端添加六聚体重复序列,它可防止端粒丢失,从而避免细胞进入衰老状态。最近的数据表明,人类端粒酶逆转录酶亚基(hTERT)的表达是端粒酶活性的限制因素。为深入了解调节hTERT表达的机制,我们确定了hTERT基因的完整基因组结构,并分离出其5'和3'侧翼区域。hTERT基因全长超过37kb,由16个外显子组成。我们发现,迄今为止描述的所有hTERT插入和缺失变体很可能是由于内含子或外显子区域中选择性剪接共有序列的使用所致。此外,我们还鉴定出一种新的hTERT剪接变体。对假定转录起始区域周围DNA序列的分析揭示了一个位于CpG岛中的无TATA框启动子。一个跨越起始ATG起始密码子上游前1100bp的启动子片段在HEK-293细胞中表现出高水平活性。在该启动子区域鉴定出了几个转录因子Sp1的共有结合位点以及一个c-Myc结合位点。总之,这些结果为更详细地研究正常细胞和癌细胞中端粒酶活性的调节提供了基础,并可能促使开发新的癌症治疗方法。